AML cells have higher expression of METTL3 compared to HSPCs and a CRISPR dropout screen identified METTL3, METTL14, WTAP and KIAA1429 as essential for the survival of AML cells, indicating a potential oncogenic role for m6A modification in AML [36]. Here, VIRMA is linked to acute myeloid leukemia.